Search Cosmetics & Toiletries: Page 4

234 Results

Section: Regulations > Regional

CT.com_skin_exposure_in_pool

CTFA Files Nanoparticles Commentary with FDA

The Cosmetic, Toiletry and Fragrance Association (CTFA) announced it has filed comprehensive comments with the FDA regarding nanoparticles in personal care products.

FDA Issues Final Guidance on Nanomaterials

On June 26, 2014, The U.S. Food and Drug Administration (FDA) issued Final Guidance for Industry: Safety of Nanomaterials in Cosmetics, a final guidance document addressing the use of nanotechnology in cosmetics.

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation, thereby, treating patients with alopecia areata.

FDA Approves First Systemic Alopecia Areata Treatment

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.

BabyPowderSpill850x425

FDA Alert: New J&J Baby Powder Recall

According to the FDA, a test sample from one lot was found to contain chrysotile fibers, a type of asbestos. As such, Oct. 18, 2019, Johnson & Johnson voluntarily recalled the product.

850x425_tattoofda

FDA Recalls Tattoo Inks for Bacteria Contamination

The tattoo inks were manufactured or distributed by four firms inspected under an ongoing assignment.

FDA Finds Harmful Bacteria in Antimicrobial Products

The US Food and Drug Administration (FDA) has warned consumers to avoid the use of Clarcon skin products. According to the FDA, there is a risk of bacterial contamination associated with the products.

850x425_icmadfda

ICMAD to Host FDA Cosmetics Regulations Workshop

The meeting will include a mixture of presentations and panel discussion on topics related to manufacturers and marketers of cosmetics and over-the-counter (OTC) drugs, such as I.S. FDA activities and changes in OTC drug regulations

ADA Requests Tooth Whitener Classification from FDA

The American Dental Association (ADA) has published a statement requesting that the US Food and Drug Administration (FDA) establish appropriate classifications for tooth-whitening chemicals.

Fda Q4 Color Additives

FDA Releases Color Additives Q4 Report

The U.S. Food and Drug Administration (FDA) has posted to its website the fourth quarter 2020 report on color additive certifications.

FDA Issues Warning Letter for Injectable Tan Product

The US Food and Drug Administration (FDA) has issued a warning letter to Melanocorp Inc. concerning the sale and marketing of the product Melanotan II.

Pf Fda Lead 4319

FDA Talks Cannabis Next Steps, Announces Public Hearing

The new steps will include the creation of an eternal agency that will explore potential pathways for the lawful marketing of products with CBD.

850_shampoobottle1

Antibacterial Soap? You Can Skip It, Says FDA

The FDA is issuing a final rule under which OTC consumer antiseptic wash products containing the majority of the antibacterial active ingredients—including triclosan and triclocarban—will no longer be able to be marketed.

HandSanitizerBottlesLinedUp850x425

FDA to Withdraw Temporary Hand Sanitizer Production Policies

"In recent months, the supply of alcohol-based hand sanitizer from traditional suppliers has increased and now, most ... are no longer having difficulty obtaining these products. Therefore, we have determined it’s appropriate to withdraw the temporary guidances..."

PouringTalcinHand850x425

Talc Results Are In: FDA Releases 6-part Report

The U.S. Food and Drug Administration released the findings from a year-long project to test talc-containing cosmetics for the presence of asbestos. Results showed 43 samples were negative while 9 were positive.

MarijuanaCosmeticMortarPestle850x425

FDA Clears the Air on CBD Reform Efforts

While CBD is trending across market segments, the rules in play to ensure public health and market direction are baffling at best. As such, the FDA has issued an update outlining its efforts to provide clarity.

BiologyCells850

FDA Sets Regulatory Framework for Regenerative Biological Therapies

It's a sign of the times when technology and innovation hit a point where the U.S. Food and Drug Administration must stop and write new rules to ensure consumer safety. That time, with respect to regenerative biological therapies, is now.

SI_MicroneedlingTools_425

Road to Regulation: Microneedling Devices Defined by FDA

Microneedling devices have, for some time, been without widely enforced regulation. As such, the U.S. Food and Drug Administration released a draft guidance on Sept. 15, 2017, defining when tools are considered esthetic vs. medical in nature, along with potential regulatory changes.

850x425_fdaiccr

FDA to Hold Public Meeting In Preparation of ICCR Meeting

Information gathered from the public meeting will help the FDA prepare for the International Cooperation on Cosmetics Regulation-12 (ICCR-12) meeting to be held July 10-12, 2018, in Tokyo, Japan.

Page 4 of 13